Skip to content

13F-HR filed by Brookstone Capital Management

Brookstone Capital Management filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-04-16, with 502 holding rows worth $2,609,686,000.

Accession
0001062993-21-003687
Filed
2021-04-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2021

A holdings report, 502 entries on the cover page, a total value of $2,609,686,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,609,683,000 with VALUE read as thousands by filing date, 13F file number 028-15771. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GALECTIN THERAPEUTICS INC363225202COMMON STOCK12,560$27,000thousands by filing date
THERAPEUTICSMD INC88338N107COM15,300$21,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001062993-21-003687this filing2021-04-16acceptance time not in the bulk data set